Addison Whitney

💥 Pharmaceutical naming has reached its breaking point 💥   For decades, pharma naming has been stuck—limited by trademark roadblocks and regulatory hurdles, forcing teams to choose between names they love and names they can own. Why settle?    With Predictive Naming, powered by Ari™, you don’t have to ⛓️💥   Ari™ is the first AI-driven pharma naming platform, blending human creativity with advanced technology to deliver trademarks without tradeoffs.   The future of pharma naming starts today. Meet Ari™ below 👇 https://lnkd.in/esmGWdBt

This week was one for the books! Take a look at what Brad Moody got into in Philly at Pharma USA—connecting with colleagues and clients, diving into exciting AI conversations, and making the most of an action-packed week. And with conference season just getting started, there’s much more to come—stay tuned!

Joseph Daley, Bill Purdy, and Brad Moody had an amazing time at Pharma USA 2025 showcasing how Ari™—the first and only GenAI platform built for pharma naming—is transforming the way our team develops creative, compliant names. Missed us at the event? No worries! Schedule a live demo today and see how Ari™ can revolutionize your next naming project: https://lnkd.in/ezmxKR7p

We had such a good time at Pharma USA 2025! Joseph Daley teamed up with Dorothy Linvill-Neal to kick things off on stage talking about Ari™—the first GenAI platform positioned to disrupt the pharmaceutical naming process with names that are both compliant and creative. Miss the talk? Schedule a live demo of Ari™ with our team today: https://lnkd.in/ezmxKR7p

At Pharma USA 2025? Joseph Daley, Bill Purdy, & Brad Moody are live in Philly and ready to chat about your next branding project! 📍 Find them on the conference floor today to discover how our cutting-edge, AI-amplified approach can elevate your next naming project. Book a time to connect: https://lnkd.in/ebTBxEbe 💡 Don't forget to ask about Ari™, the first GenAI platform for pharma naming—built to help our creative team deliver names that are compliant, safe, and strategically powerful. Let’s build the future of pharma branding together! 🔥

Pharma USA Week is here! Join us to explore the latest in AI and pharma branding—and meet Ari™ in action. Here’s where you can find us: 🔹On the conference floor – Connect with Bill Purdy & Brad Moody and learn more about the latest in pharma branding. 🔹On stage – See Joseph Daley on the Orange Stage (March 18, 2:20 PM) presenting: "AI Use Case: Finding Trademarks Without Tradeoffs" with one of our valued clients. Not attending? No worries! You can still demo Ari™ here 👉https://lnkd.in/evrGtfHw

Have you met Ari™ yet? For decades, pharma naming has been stuck—limited by trademark roadblocks and regulatory hurdles, often forcing teams to choose between names they love and names they can own. But it's time to rethink what's possible. Join us at Pharma USA 2025, where we'll be discussing Ari—the first GenAI platform for pharmaceutical naming—and how it's transforming the industry by streamlining the journey to deliver trademarks without tradeoffs. Don’t miss the conversation at Pharma USA—or get ahead by scheduling a demo today: https://lnkd.in/ezmxKR7p.

💥The countdown to Pharma USA is on—just 1 week to go! 💥 Be among the first to experience Ari™ in person! Join Joseph Daley as he unveils the first GenAI platform revolutionizing pharma naming—bridging creativity and compliance like never before. Plus, hear firsthand from one of our valued clients about Ari’s real-world impact. Don’t miss this game-changing innovation—schedule a meeting today and connect with us on the conference floor: https://lnkd.in/eYC4EVAa

A great name isn’t just a label—it’s a powerful signal to the world. And with Ari™, we’re redefining what’s possible when it comes to Pharma naming. Our AI-driven naming platform empowers our verbal designers, like Keith B. Hepler, to unlock limitless possibilities, combining human ingenuity with cutting-edge technology to create names that inspire, differentiate, and endure. Have you had a chance to meet our newest team member, Ari™? Schedule a demo today: https://lnkd.in/ezmxKR7p

In pharmaceutical naming, safety and marketing validations have traditionally been conducted together—often leading to compromises that weaken name selection. But why settle for tradeoffs when you can have both safety and strategic impact? Predictive Naming, amplified by Ari™, is here to change the game. One of the key pillars of the Predictive Naming is Decoupled Research Validation—a reimagined approach that separates safety and marketing research, ensuring the right data guides teams to a name that’s both safe and strategically impactful. Interested in learning how Decoupled Research Validation and Ari™ work together for names without tradeoffs? ⬇️ Head to the link to schedule a demo and get a free white paper download to learn more: https://lnkd.in/eZWjMczJ